Domine Gomez, Manuel manuel.domine@uam.es
Publications
- Articles 38
- Books 1
- Book chapters 0
- Conferences 0
- Working papers 0
- Technical reports 0
- Research projects 0
- Supervised theses 0
- Patent or software license 0
RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC
- Hernandez, S
- Carrillo, JLR
- Caminoa, A
- Benito, A
- Martinez, R
- Alonso, M
- Clave, S
- Arriola, E
- Esteban-Rodriguez, I
- De Castro, J
- Sansano, I
- Felip, E
- Abdulkader, I
- Garcia, J
- Rojo, F
- Domine, M
- Teixido, C
- Reguart, N
- Compan, D
- Insa, A
- Mancheno, N
- Palanca, S
- Juan, O
- Baixeras, N
- Nadal, E
- Cebollero, M
- Calles, A
- Martin, P
- Salas, C
- Provencio, M
- Aranda, I
- Massuti, B
- Lopez-Vilaro, L
- Majem, M
- Garrido, P
- Paz-Ares, L
- Lopez-Rios, F
- Conde, E
Journal Of Thoracic Oncology (p. S135-S136) - 1/9/2022
- ISSN 15560864
- iMarina
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
- Wu, YL
- John, T
- Grohe, C
- Majem, M
- Goldman, JW
- Kim, SW
- Kato, T
- Laktionov, K
- Vu, HV
- Wang, ZJ
- Lu, S
- Lee, KY
- Akewanlop, C
- Yu, CJ
- de Marinis, F
- Bonanno, L
- Domine, M
- Shepherd, FA
- Zeng, LM
- Atasoy, A
- Herbst, RS
- Tsuboi, M
Journal Of Thoracic Oncology (p. 423-433) - 1/3/2022
10.1016/j.jtho.2021.10.014 View at source
- ISSN 15560864
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
- Provencio M
- Serna-Blasco R
- Nadal E
- Insa A
- García-Campelo MR
- Casal Rubio J
- Dómine M
- Majem M
- Rodríguez-Abreu D
- Martínez-Martí A
- De Castro Carpeño J
- Cobo M
- López Vivanco G
- Del Barco E
- Bernabé Caro R
- Viñolas N
- Barneto Aranda I
- Viteri S
- Pereira E
- Royuela A
- Calvo V
- Martín-López J
- García-García F
- Casarrubios M
- Franco F
- Sánchez-Herrero E
- Massuti B
- Cruz-Bermúdez A
- Romero A
Journal Of Clinical Oncology (p. 2924-2933) - 1/5/2022
10.1200/jco.21.02660 View at source
- ISSN 0732183X
NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases
- Nadal, E
- Cantero, A
- Ortega, AL
- Domine, M
- Barba, A
- Blasco, A
- Garcia, J
- Mosquera, J
- Vazquez, S
- Rodriguez, D
- Lopez-Castro, R
- Juan Vidal, O
- Sanchez, A
- Paz Ares, L
- Hernandez, A
- Iranzo, P
- Diz, P
- Provencio, M
- Simo, M
- Navarro, V
- Bruna, J
Journal Of Thoracic Oncology (p. S350-S351) - 1/9/2022
- ISSN 15560864
- iMarina
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
- Sanchez-Herrero, Estela
- Serna-Blasco, Roberto
- Ivanchuk, Vadym
- Garcia-Campelo, Rosario
- Gomez, Manuel Domine
- Sanchez, Jose M.
- Massuti, Bartomeu
- Reguart, Noemi
- Camps, Carlos
- Sanz-Moreno, Sandra
- Calabuig-Farinas, Silvia
- Jantus-Lewintre, Eloisa
- Arnal, Magdalena
- Fernandez-Orth, Dietmar
- Calvo, Virginia
- Gonzalez-Rumayor, Victor
- Provencio, Mariano
- Romero, Atocha;
Molecular Oncology (p. 2363-2376) - 1/9/2021
10.1002/1878-0261.13033 View at source
- ISSN 15747891
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: A phase Ib/randomized phase II trial
- Weiss JM, Csoszi T, Maglakelidze M, Hoyer RJ, Beck JT, Domine Gomez M, Lowczak A, Aljumaily R, Rocha Lima CM, Boccia RV, Hanna W, Nikolinakos P, Chiu VK, Owonikoko TK, Schuster SR, Hussein MA, Richards DA, Sawrycki P, Bulat I, Hamm JT, Hart LL, Adler S, Antal JM, Lai AY, Sorrentino JA, Yang Z, Malik RK, Morris SR, Roberts PJ, Dragnev KH, G1T28-02 Study Group
Annals Of Oncology (p. 1613-1621) - 1/10/2019
10.1093/annonc/mdz278 View at source
- ISSN 09237534
Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non-small cell lung cancer.
- Ferrer, L
- Nadal, E
- Guidel, F
- Insa, A
- Menu, P
- Casal, J
- Domine, M
- Massuti, B
- Majem, M
- Martinez-Marti, A
- Campelo, RG
- Carpeon, JD
- Cobo, M
- Vivanco, GL
- del Barco, E
- Bernabe, R
- Vinolas, N
- Barneto, I
- Colin, T
- Provencio-Pulla, M
Journal Of Clinical Oncology - 1/6/2022
- ISSN 0732183X
- iMarina
Multidisciplinary Thoracic Tumors Board Survey in Spain
- Massuti, B
- Nadal, E
- Camps, C
- Carcereny, E
- Cobo, M
- Domine, M
- Garcia-Campelo, MR
- Gonzalez-Larriba, JL
- Guirado, M
- Hernando-Trancho, F
- Rodriguez-Abreu, D
- Sanchez, A
- Sullivan, I
- Provencio, M
Journal Of Thoracic Oncology (p. S107-S107) - 1/9/2022
- ISSN 15560864
- iMarina
Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation
- Serna-Blasco R
- Sánchez-Herrero E
- Robado de Lope L
- Sanz-Moreno S
- Rodríguez-Festa A
- Ares-Trotta D
- Cruz-Bermúdez A
- Franco F
- Sánchez-Hernández A
- Campayo MdJ
- García-Girón C
- Dómine M
- Blasco A
- Sánchez JM
- Oramas J
- Bosch-Barrera J
- Sala MA
- Sereno M
- Romero A
- Provencio M
Cancers - 1/9/2022
10.3390/cancers14184446 View at source
- ISSN 20726694
Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy
- De Castro, J.
- González-Larriba, J.L.
- Vázquez, S.
- Massutí, B.
- Sanchez-Torres, J.M.
- Dómine, M.
- Garrido, P.
- Calles, A.
- Artal, A.
- Collado, R.
- García, R.
- Sereno, M.
- Majem, M.
- Macías, J.A.
- Juan, O.
- Gómez-Codina, J.
- Hernández, B.
- Lázaro, M.
- Ortega, A.L.
- Cobo, M.
- Trigo, J.M.
- Carcereny, E.
- Rolfo, C.
- Macia, S.
- Muñoz, J.
- Diz, P.
- Méndez, M.
- Rosillo, F.
- Paz-Ares, L.
- Cardona, J.V.
- Isla, D.
Clinical & Translational Oncology (p. 219-226) - 1/2/2017
Editor: Springer-Verlag Italia s.r.l.
10.1007/s12094-016-1527-8 View at source
- ISSN 1699048X
- ISSN/ISBN 1699-3055
This researcher has no book chapters.
This researcher has no conferences.
This researcher has no working papers.
This researcher has no technical reports.
This researcher has no research projects.
This researcher has no supervised thesis.
This researcher has no patents or software licenses.
Researcher profiles
-
ORCID
-
Scopus Author ID
-
Dialnet id